Abstract
Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 269-271 |
| Number of pages | 3 |
| Journal | Infectious Diseases in Clinical Practice |
| Volume | 21 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Ceftaroline
- Osteomyelitis
- Staphylococcus aureus
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Use of ceftaroline in the management of vertebral osteomyelitis case report'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS